3 ms·
Insurers (whether companies or government schemes) will only have to pay $56,000 a year for this treatment. I wonder how much the FDA increases healthcare cost
by missedthecue 5y ago
Insurers (whether companies or government schemes) will only have to pay $56,000 a year for this treatment.
I wonder how much the FDA increases healthcare costs. Biogen has been trying to get the approved for a very long time. I'm sure they're starting out maybe five to ten billion in the red on this product.
- olliej 5y agoThe FDA doesn't meaningfully impact costs, unless you include "testing to make sure it's safe" as a cost. I would have said efficacy as well, except the evidence doesn't suggest that this drug does anything except empty people's wallets in exchange for false hope.
- brianwawok 5y agoIt’s not the FDAs job to approve or not things based on price. It’s their job to approve things that are safe and effective. Imagine a world where a pill was made to cure all cancer, but not approved because the price was too high.
- missedthecue 5y agoI'm not saying they should regulate price, just that they are a pretty significant barrier to entry, cost a lot of American lives through inaction, and seem to miss and even endorse plenty of dangerous drugs anyway.
- oldgradstudent 5y agoManufacturers price their product to maximize profits, regardless of the sunk costs. If they have thought pricing it at $100,000/year would have brought more profits they would have priced it at $100K, and if they thought pricing it at $25,000/year would have brought more profits they would have priced it at $25K.